A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

Clinical trial NCT07354724 · RECRUITING

Trial details

NCT number: NCT07354724
Sponsor: Denali Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Late-onset Pompe Disease

Start date: 2026-05-12
Primary completion: 2028-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.